Clinical trial
A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in…
NCT00332462 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00332462 |
|---|---|
| Title | A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients |
| Official title | A Multicenter, Open-label, Exploratory Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine During the First 7 Days Post Transplant Followed by Treatment With Cyclosporine Micro Emulsion in de Novo Liver Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | Cyclosporine (Sandimmun® i.v.), Cyclosporine (Sandimmun® Optoral) |
| Enrollment | 34 |
| Start date | May 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jun 1, 2006 |
| Last update posted | Mar 7, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: